Immunohistochemical Pitfalls and the Importance of Glypican-3 in the Diagnosis of Scirrhous Hepatocellular Carcinoma

被引:0
|
作者
Krings, G.
Jain, D.
Wu, T-T
Yeh, M.
Torbenson, M.
Kakar, S.
机构
[1] UCSF, San Francisco, CA USA
[2] Yale Univ, New Haven, CT USA
[3] Mayo Clin, Rochester, MN USA
[4] Univ Washington, Seattle, WA 98195 USA
[5] Johns Hopkins, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1553
引用
收藏
页码:366A / 366A
页数:1
相关论文
共 50 条
  • [31] Imaging the expression of glypican-3 in hepatocellular carcinoma by PET
    Zhen Wang
    Yan-Jiang Han
    Shun Huang
    Meng Wang
    Wen-Lan Zhou
    Hong-Sheng Li
    Quan-Shi Wang
    Hu-Bing Wu
    Amino Acids, 2018, 50 : 309 - 320
  • [32] Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
    Li Wang
    Min Yao
    Liu-Hong Pan
    Qi Qian
    Deng-Fu Yao
    Hepatobiliary & Pancreatic Diseases International, 2015, 14 (04) : 361 - 366
  • [33] Glypican-3 and Alphafetoprotein as Diagnostic Tests for Hepatocellular Carcinoma
    Jorge Filmus
    Mariana Capurro
    Molecular Diagnosis, 2004, 8 (4) : 207 - 212
  • [34] Glypican-3 is a biomarker and a therapeutic target of hepatocellular carcinoma
    Wang, Li
    Yao, Min
    Pan, Liu-Hong
    Qian, Qi
    Yao, Deng-Fu
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (04) : 361 - 366
  • [35] Identification of microRNAs controlling Glypican-3 expression in hepatocellular carcinoma
    Maurel, M.
    Ladeiro, Y.
    Jalvy-Delvaille, S.
    Pitard, V.
    Vachet, L.
    Combe, C.
    Sagliocco, F.
    Zucman-Rossi, I.
    Laloo, B.
    Grosset, C.
    BULLETIN DU CANCER, 2011, 98 : S43 - S44
  • [36] Peptide Binder to Glypican-3 as a Theranostic Agent for Hepatocellular Carcinoma
    Lin, Fanching
    Clift, Renee
    Ehara, Takeru
    Yanagida, Hayato
    Horton, Steven
    Noncovich, Alain
    Guest, Matt
    Kim, Daniel
    Salvador, Katrina
    Richardson, Samantha
    Miller, Terra
    Han, Guangzhou
    Bhat, Abhijit
    Song, Kenneth
    Li, Gary
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (04) : 586 - 592
  • [37] Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma
    Kaseb, Ahmed Omar
    Hassan, Manal
    Lacin, Sahin
    Abdel-Wahab, Reham
    Amin, Hesham M.
    Shalaby, Ahmed
    Wolff, Robert A.
    Yao, James
    Rashid, Asif
    Vennapusa, Bharathi
    Feng, Janine
    Ohtomo, Toshihiko
    ONCOTARGET, 2016, 7 (43) : 69916 - 69926
  • [38] Glypican-3: A novel diagnostic marker for hepatocellular carcinoma.
    Sherman, M
    Filmus, J
    Wanless, I
    Capurro, M
    HEPATOLOGY, 2002, 36 (04) : 692A - 692A
  • [39] Glypican-3 A Novel Diagnostic Marker for Hepatocellular Carcinoma and More
    Kandil, Dina H.
    Cooper, Kumarasen
    ADVANCES IN ANATOMIC PATHOLOGY, 2009, 16 (02) : 125 - 129
  • [40] ImmunoPET as Stoichiometric Sensor for Glypican-3 in Models of Hepatocellular Carcinoma
    Kelada, O. J.
    Gutsche, N. T.
    Bell, M.
    Berman, R. M.
    Baidoo, K. E.
    Warner, B. M.
    Szajek, L. P.
    Hong, J.
    Ho, M.
    Choyke, P.
    Escorcia, F. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : S180 - S181